{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:50:46Z","timestamp":1767855046337,"version":"3.49.0"},"reference-count":52,"publisher":"Impact Journals, LLC","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Oncotarget"],"published-print":{"date-parts":[[2018,1,5]]},"DOI":"10.18632\/oncotarget.22930","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T20:24:38Z","timestamp":1512505478000},"page":"1868-1884","source":"Crossref","is-referenced-by-count":22,"title":["Hypericin targets osteoclast and prevents breast cancer-induced bone metastasis via NFATc1 signaling pathway"],"prefix":"10.18632","volume":"9","author":[{"given":"Zhengxiao","family":"Ouyang","sequence":"first","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaoning","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bo","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziqing","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zanjing","family":"Zhai","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinhua","family":"Qu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, Shanghai Ninth People's Hospital, Shanghai Jiaotong University School of Medicine, Shanghai, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuqiang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The First Affiliated Hospital of Nanchang University, Artificial Joints Engineering and Technology Research Center of Jiangxi Province, Nanchang, Jiangxi, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dan","family":"Peng","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yi","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tang","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qing","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Orthopedics, The Second Xiangya Hospital, Central South University, Changsha, Hunan, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2017,12,4]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1001\/jama.2016.19425","article-title":"Effect of Longer-Interval vs Standard Dosing of Zoledronic Acid on Skeletal Events in Patients With Bone Metastases: A Randomized Clinical Trial","volume":"317","author":"O'Mara","year":"2017","journal-title":"Jama"},{"key":"2","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.bone.2014.01.015","article-title":"Circulating interleukin-8 levels explain breast cancer osteolysis in mice and humans","volume":"61","author":"Montgomery","year":"2014","journal-title":"Bone"},{"key":"3","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1007\/s11914-010-0012-5","article-title":"Adjuvant bisphosphonates in breast cancer: the ABCSG-12 study","volume":"8","author":"Suva","year":"2010","journal-title":"Curr Osteoporos Rep"},{"key":"4","doi-asserted-by":"publisher","first-page":"906","DOI":"10.1001\/jamaoncol.2016.6316","article-title":"Continued Treatment Effect of Zoledronic Acid Dosing Every 12 vs 4 Weeks in Women With Breast Cancer Metastatic to Bone: The OPTIMIZE-2 Randomized Clinical Trial","volume":"3","author":"Lipton","year":"2017","journal-title":"JAMA Oncol"},{"key":"5","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1016\/j.addr.2015.11.017","article-title":"Heterogeneity of tumor cells in the bone microenvironment: Mechanisms and therapeutic targets for bone metastasis of prostate or breast cancer","volume":"99","author":"Suzui","year":"2016","journal-title":"Adv Drug Deliv Rev"},{"key":"6","doi-asserted-by":"publisher","first-page":"1764","DOI":"10.3390\/ijms17101764","article-title":"What Is Breast in the Bone?","volume":"17","author":"Forsyth","year":"2016","journal-title":"International Journal of Molecular Sciences"},{"key":"7","doi-asserted-by":"publisher","first-page":"1221","DOI":"10.1200\/jco.2010.32.5209","article-title":"American Society of Clinical Oncology executive summary of the clinical practice guideline update on the role of bone-modifying agents in metastatic breast cancer","volume":"29","author":"Von Roenn","year":"2011","journal-title":"J Clin Oncol"},{"key":"8","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1038\/nrc3055","article-title":"Cancer to bone: a fatal attraction","volume":"11","author":"McCauley","year":"2011","journal-title":"Nat Rev Cancer"},{"key":"9","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1016\/j.breast.2014.05.023","article-title":"Bone health in breast cancer patients: a comprehensive statement by CECOG\/SAKK Intergroup","volume":"23","author":"Tesarova","year":"2014","journal-title":"Breast"},{"key":"10","doi-asserted-by":"publisher","first-page":"1419","DOI":"10.1016\/j.drudis.2014.04.004","article-title":"Therapeutic strategies for treating osteolytic bone metastases","volume":"19","author":"Bouler","year":"2014","journal-title":"Drug Discov Today"},{"key":"11","doi-asserted-by":"publisher","first-page":"1134","DOI":"10.1016\/j.yexcr.2011.02.008","article-title":"Anti-tumor effect in human breast cancer by TAE226, a dual inhibitor for FAK and IGF-IRand","volume":"317","author":"Sasaki","year":"2011","journal-title":"Exp Cell Res"},{"key":"12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1211\/0022357011775910","article-title":"St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical properties","volume":"53","author":"Phillipson","year":"2001","journal-title":"J Pharm Pharmacol"},{"key":"13","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1016\/s0140-6736(99)05712-8","article-title":"Indinavir concentrations and St John's wort","volume":"355","author":"Falloon","year":"2000","journal-title":"Lancet"},{"key":"14","doi-asserted-by":"publisher","first-page":"276","DOI":"10.1016\/j.bcp.2014.06.009","article-title":"Hypericin suppresses osteoclast formation and wear particle-induced osteolysis via modulating ERK signalling pathway","volume":"90","author":"Dai","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1186\/s12935-016-0279-4","article-title":"Cytotoxic and apoptogenic effect of hypericin, the bioactive component of Hypericum perforatum on the MCF-7 human breast cancer cell line","volume":"1","author":"Alizadeh-Navaei","year":"2015","journal-title":"Cancer Cell Int"},{"key":"16","first-page":"627","article-title":"The effects of hypericin on ADAMTS and p53 gene expression in MCF-7 breast cancer cells","volume":"19","author":"Gunduz","year":"2014","journal-title":"J buon"},{"key":"17","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.bcp.2014.06.005","article-title":"Trolox inhibits osteolytic bone metastasis of breast cancer through both PGE2-dependent and independent mechanisms","volume":"91","author":"Lee","year":"2014","journal-title":"Biochem Pharmacol"},{"key":"18","first-page":"199","article-title":"Expression profile of receptor activator of nuclear-kappaB (RANK), RANK ligand (RANKL) and osteoprotegerin (OPG) in breast cancer","volume":"33","author":"Jiang","year":"2013","journal-title":"Anticancer Res"},{"key":"19","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1016\/j.jbo.2016.02.008","article-title":"The role of osteoclasts in breast cancer bone metastasis","volume":"5","author":"Cl\u00e9zardin","year":"2016","journal-title":"Journal of Bone Oncology"},{"key":"20","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1600-065X.2009.00821.x","article-title":"Ca2+-NFATc1 signaling is an essential axis of osteoclast differentiation","volume":"231","author":"Takayanagi","year":"2009","journal-title":"Immunol Rev"},{"key":"21","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1016\/j.bbamcr.2010.11.002","article-title":"Calcium signaling in osteoclasts","volume":"1813","author":"Putney","year":"2011","journal-title":"Biochim Biophys Acta"},{"key":"22","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.breast.2016.09.017","article-title":"Breast cancer osteomimicry and its role in bone specific metastasis; an integrative, systematic review of preclinical evidence","volume":"30","author":"Lavender","year":"2016","journal-title":"Breast"},{"key":"23","doi-asserted-by":"publisher","first-page":"3071","DOI":"10.1158\/1078-0432.ccr-13-1590","article-title":"Molecular mechanisms of bone metastasis and associated muscle weakness","volume":"20","author":"Guise","year":"2014","journal-title":"Clin Cancer Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1186\/s13058-014-0458-y","article-title":"Tumor-expressed adrenomedullin accelerates breast cancer bone metastasis","volume":"16","author":"Chirgwin","year":"2014","journal-title":"Breast Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1007\/s12282-016-0732-1","article-title":"Recent development of targeted approaches for the treatment of breast cancer","volume":"24","author":"Kotoky","year":"2017","journal-title":"Breast Cancer"},{"key":"26","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1016\/j.bone.2014.06.017","article-title":"CSF-1 blockade impairs breast cancer osteoclastogenic potential in co-culture systems","volume":"66","author":"Zoli","year":"2014","journal-title":"Bone"},{"key":"27","doi-asserted-by":"publisher","first-page":"332","DOI":"10.1159\/000368844","article-title":"Side effects of bone-targeted therapies in advanced breast cancer","volume":"9","author":"Schuetz","year":"2014","journal-title":"Breast Care (Basel)"},{"key":"28","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/jb\/mvv112","article-title":"The role of osteoclast differentiation and function in skeletal homeostasis","volume":"159","author":"Takeshita","year":"2016","journal-title":"J Biochem"},{"key":"29","doi-asserted-by":"publisher","first-page":"215","DOI":"10.1186\/bcr2781","article-title":"Breast cancer metastasis to the bone: mechanisms of bone loss","volume":"12","author":"Mastro","year":"2010","journal-title":"Breast Cancer Res"},{"key":"30","doi-asserted-by":"publisher","first-page":"250","DOI":"10.1186\/1471-2474-11-250","article-title":"Screening of protein kinase inhibitors identifies PKC inhibitors as inhibitors of osteoclastic acid secretion and bone resorption","volume":"11","author":"Henriksen","year":"2010","journal-title":"BMC Musculoskelet Disord"},{"key":"31","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1006\/excr.1999.4714","article-title":"Intracellular calcium puffs in osteoclasts","volume":"253","author":"Blair","year":"1999","journal-title":"Exp Cell Res"},{"key":"32","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","article-title":"Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts","volume":"3","author":"Kodama","year":"2002","journal-title":"Dev Cell"},{"key":"33","doi-asserted-by":"publisher","first-page":"260","DOI":"10.1016\/j.ceca.2010.09.010","article-title":"RANKL-induced TRPV2 expression regulates osteoclastogenesis via calcium oscillations","volume":"48","author":"Okabe","year":"2010","journal-title":"Cell Calcium"},{"key":"34","doi-asserted-by":"publisher","first-page":"1069","DOI":"10.1002\/jcb.23439","article-title":"Variability of the paracrine-induced osteoclastogenesis by human breast cancer cell lines","volume":"113","author":"Fernandes","year":"2012","journal-title":"J Cell Biochem"},{"key":"35","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1007\/s10549-012-2222-2","article-title":"RANKL inhibition combined with tamoxifen treatment increases anti-tumor efficacy and prevents tumor-induced bone destruction in an estrogen receptor-positive breast cancer bone metastasis model","volume":"135","author":"Dougall","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"36","doi-asserted-by":"publisher","first-page":"178","DOI":"10.5312\/wjo.v4.i4.178","article-title":"Role of RANKL\/RANK in primary and secondary breast cancer","volume":"4","author":"Hata","year":"2013","journal-title":"World J Orthop"},{"key":"37","doi-asserted-by":"publisher","first-page":"223","DOI":"10.4149\/gpb_2015045","article-title":"Photoactivated hypericin is not genotoxic","volume":"35","author":"Miadokova","year":"2016","journal-title":"Gen Physiol Biophys"},{"key":"38","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1002\/path.2265","article-title":"Primary tumour expression of the cysteine cathepsin inhibitor Stefin A inhibits distant metastasis in breast cancer","volume":"214","author":"Anderson","year":"2008","journal-title":"J Pathol"},{"key":"39","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1016\/j.bone.2014.06.023","article-title":"Modifying the osteoblastic niche with zoledronic acid-potential implications for breast cancer bone metastasis","volume":"66","author":"Brown","year":"2014","journal-title":"Bone"},{"key":"40","doi-asserted-by":"publisher","first-page":"539","DOI":"10.1038\/nm.4076","article-title":"LGR4 is a receptor for RANKL and negatively regulates osteoclast differentiation and bone resorption","volume":"22","author":"Yang","year":"2016","journal-title":"Nat Med"},{"key":"41","doi-asserted-by":"publisher","first-page":"40487","DOI":"10.1038\/srep40487","article-title":"Osteoclastic miR-214 targets TRAF3 to contribute to osteolytic bone metastasis of breast cancer","volume":"7","author":"Wang","year":"2017","journal-title":"Sci Rep"},{"key":"42","doi-asserted-by":"publisher","first-page":"542","DOI":"10.1016\/j.ccr.2013.09.008","article-title":"Tumor-induced osteoclast miRNA changes as regulators and biomarkers of osteolytic bone metastasis","volume":"24","author":"Kang","year":"2013","journal-title":"Cancer Cell"},{"key":"43","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1038\/nm.2830","article-title":"Silencing of Irf7 pathways in breast cancer cells promotes bone metastasis through immune escape","volume":"18","author":"Argani","year":"2012","journal-title":"Nat Med"},{"key":"44","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2174\/1381612053382287","article-title":"Hypericin--the facts about a controversial agent","volume":"11","author":"Grunberger","year":"2005","journal-title":"Curr Pharm Des"},{"key":"45","doi-asserted-by":"publisher","first-page":"1655","DOI":"10.1056\/NEJMra030831","article-title":"Mechanisms of bone metastasis","volume":"350","author":"Roodman","year":"2004","journal-title":"N Engl J Med"},{"key":"46","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S0093-7754(01)90225-8","article-title":"Preclinical models of bone metastases","volume":"28","author":"Mundy","year":"2001","journal-title":"Semin Oncol"},{"key":"47","doi-asserted-by":"publisher","first-page":"3302","DOI":"10.1158\/0008-5472.can-15-0240","article-title":"ITGBL1 Is a Runx2 Transcriptional Target and Promotes Breast Cancer Bone Metastasis by Activating the TGFbeta Signaling Pathway","volume":"75","author":"Feng","year":"2015","journal-title":"Cancer Res"},{"key":"48","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/s10585-011-9438-0","article-title":"Analysis of a bone metastasis gene expression signature in patients with bone metastasis from solid tumors","volume":"29","author":"Costa","year":"2012","journal-title":"Clin Exp Metastasis"},{"key":"49","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/1742-4690-5-1","article-title":"Expression of infectious murine leukemia viruses by RAW264.7 cells, a potential complication for studies with a widely used mouse macrophage cell line","volume":"5","author":"Ward","year":"2008","journal-title":"Retrovirology"},{"key":"50","doi-asserted-by":"publisher","first-page":"5721","DOI":"10.1016\/j.biomaterials.2014.04.006","article-title":"The effect of enoxacin on osteoclastogenesis and reduction of titanium particle-induced osteolysis via suppression of JNK signaling pathway","volume":"35","author":"Dai","year":"2014","journal-title":"Biomaterials"},{"key":"51","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1007\/s00198-016-3496-8","article-title":"Xanthotoxin prevents bone loss in ovariectomized mice through the inhibition of RANKL-induced osteoclastogenesis","volume":"27","author":"Dong","year":"2016","journal-title":"Osteoporos Int"},{"key":"52","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.3892\/mmr.2014.2872","article-title":"Inhibition of MDA-MB-231 breast cancer cell migration and invasion activity by andrographolide via suppression of nuclear factor-kappaB-dependent matrix metalloproteinase-9 expression","volume":"11","author":"Qin","year":"2015","journal-title":"Mol Med Rep"}],"container-title":["Oncotarget"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22930","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,5,9]],"date-time":"2020-05-09T10:40:27Z","timestamp":1589020827000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.oncotarget.com\/lookup\/doi\/10.18632\/oncotarget.22930"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,4]]},"references-count":52,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,1,5]]}},"alternative-id":["22930","29416737"],"URL":"https:\/\/doi.org\/10.18632\/oncotarget.22930","relation":{},"ISSN":["1949-2553"],"issn-type":[{"value":"1949-2553","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,4]]}}}